Two-Year Outcomes of the Paul Glaucoma Implant for Treatment of Glaucoma.

ABSTRACT:

Purpose

To determine 2-year efficacy of the PAUL Glaucoma Implant (PGI), a novel glaucoma tube shunt in patients with advanced glaucoma.

Participants

Patients with glaucoma refractory to maximum medical therapy or previous failed glaucoma surgery.

Methods

Retrospective review of all patients who had underwent PGI implantation in a single tertiary institution between May 1, 2017 and March 30, 2021.

Main outcome measures

Primary outcome measure was failure defined as intraocular pressure (IOP) >18 mm Hg or <6 mm Hg on 2 consecutive visits after 3 months, reoperation for IOP-related indication, explantation of implant or loss of light perception vision. Complete success was defined as unmedicated IOP ≤18 mm Hg or ≥6 mm Hg in the absence of failure.

Results

SUBMITTER: Tan MCJ 

PROVIDER: S-EPMC9148669 | biostudies-literature | 2022 Jun

REPOSITORIES: biostudies-literature